Kishor Peter Soparkar
2021
Compensation breakdown
| Non-Equity Incentive Plan | $175,175 |
|---|---|
| Option Awards | $1,667,712 |
| Salary | $435,772 |
| Stock Awards | $181,868 |
| Other | $11,600 |
| Total | $2,472,127 |
Soparkar received $1.7M in option awards, accounting for 67% of the total pay in 2021.
Soparkar also received $175.2K in non-equity incentive plan, $435.8K in salary, $181.9K in stock awards and $11.6K in other compensation.
Rankings
In 2021, Kishor Peter Soparkar's compensation ranked 5,194th out of 12,415 executives tracked by ExecPay. In other words, Soparkar earned more than 58.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,194 out of 12,415 | 58th |
Division Manufacturing | 2,184 out of 5,505 | 60th |
Major group Chemicals And Allied Products | 945 out of 2,375 | 60th |
Industry group Drugs | 845 out of 2,096 | 60th |
Industry Biological Products, Except Diagnostic Substances | 207 out of 449 | 54th |
Pay ratio
| Kishor Peter Soparkar's Pay | $2,472,127 |
|---|---|
| Median Employee's Pay | $188,229 |
| Pay Ratio | 13to 1 |
In 2021, the annual total compensation of Kishor Peter Soparkar was $2,472,127.
The annual total compensation of the median employee at Avalanche Biotechnologies was $188,229.
The ratio of Kishor Peter Soparkar's pay to the pay of median employee was therefore 13 to one.
Soparkar's colleagues
We found nine more compensation records of executives who worked with Kishor Peter Soparkar at Avalanche Biotechnologies in 2021.
2021
Laurent Fischer
Avalanche Biotechnologies
Chief Executive Officer
2021
Christopher DeRespino
Avalanche Biotechnologies
Chief Financial Officer
2021
Angela Thedinga
Avalanche Biotechnologies
Chief Technology Officer
2021
Leone Patterson
Avalanche Biotechnologies
Chief Financial Officer
2021
Julie Clark
Avalanche Biotechnologies
Chief Medical Officer
2021
Brigit Riley
Avalanche Biotechnologies
Chief Scientific Officer
2021
Rupert D'Souza
Avalanche Biotechnologies
Chief Financial Officer
2021
Thomas Leung
Avalanche Biotechnologies
Chief Financial Officer
2021
Jack Thrift
Avalanche Biotechnologies